Could Aspirin Really Prevent Colon Cancer?
- 5 December 1991
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 325 (23) , 1644-1646
- https://doi.org/10.1056/nejm199112053252309
Abstract
IN the United States, tumors of the colon and rectum account for approximately 15 percent of all visceral cancers and about 12 percent of all deaths from cancer. During the past several decades, the incidence of these cancers has remained relatively constant, and the associated mortality has declined only slightly, despite intensive attempts at earlier detection and better treatment. Research into ways to lessen the incidence or mortality has yielded only equivocal results. In several large ongoing studies conducted for up to 12 years, no clear reduction in mortality has resulted from screening for occult blood in feces.1 Among the . . .Keywords
This publication has 7 references indexed in Scilit:
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991
- Sulindac causes regression of rectal polyps in familial adenomatous polyposisGastroenterology, 1991
- Screening for Colorectal CancerNew England Journal of Medicine, 1991
- Aspirin use and chronic diseases: a cohort study of the elderly.BMJ, 1989
- The search for the causes of breast and colon cancerNature, 1989
- 16,16-Dimethyl prostaglandin E2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirinGastroenterology, 1985
- Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugsBritish Journal of Cancer, 1980